Innovation

Mater Private in breakthrough trial of new technologies to treat Atrial Fibrillation – 80% of patients treated made full recovery after 12 months

Mater-Private-jpg

Thousands of patients each year could be spared potential lifelong treatment of the most common form of cardiac arrhythmia (irregular heartbeat), atrial fibrillation, thanks to earlier diagnosis and more advanced technology.

The Mater Private Dublin was the first hospital in Ireland and one of just 17 European centres to introduce new cardiac ablation technology, which significantly improves the quality of life and reduces a patient’s time spent in surgery/treatment and in many cases.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free